Covered recipient · General Payments record
LAWRENCE GELLER
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$2,286.72
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $451.99 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $166.40 | 7 |
| BOSTON SCIENTIFIC CORPORATION | $140.06 | 1 |
| Axonics Modulation Technologies, Inc. | $59.06 | 2 |
| Teleflex LLC | $21.13 | 1 |
| ABBVIE INC. | $20.98 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $17.41 | 1 |
| COLOPLAST CORP | $13.76 | 1 |
| Laborie Medical Technologies Corp. | $13.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.98 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103785747 | CMS |
| Axonics, Inc. | $28.08 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142389232 | CMS |
| Axonics, Inc. | $30.98 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142389266 | CMS |
| Boston Scientific Corporation | $140.06 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092501616 | CMS |
| COLOPLAST CORP | $13.76 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117428631 | CMS |
| Laborie Medical Technologies Corp. | $13.19 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154322894 | CMS |
| Medtronic, Inc. | $4.35 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119455769 | CMS |
| Medtronic, Inc. | $113.43 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119455767 | CMS |
| Medtronic, Inc. | $4.10 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119455771 | CMS |
| Medtronic, Inc. | $20.82 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119455775 | CMS |
| Medtronic, Inc. | $11.56 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119455779 | CMS |
| Medtronic, Inc. | $9.02 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119455777 | CMS |
| Medtronic, Inc. | $3.12 | 09/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119455773 | CMS |
| PROGENICS PHARMACEUTICALS, INC. | $17.41 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128512985 | CMS |
| Teleflex LLC | $21.13 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142077189 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.